The addition of combination PET/CT examinations to the radiologist’s toolbox represents one of the most significant advancements in oncological imaging in the past decade. So what does the future hold for hybrid imaging?

In a small but noteworthy fMRI study, British and Chinese researchers have found that two individuals born with a rare inability to feel physical pain evidence the same patterns of brain activity when pricked with a pin as four healthy, age-matched volunteers.  

British scientists have successfully used advanced 3D x-ray imaging technology to image an aggressive form of lung disease in a new way, providing more insight into how the disease develops inside the body.

Doctors at the Texas Center for Proton Therapy in Irving, Texas, have become the first to image patients in North America using combined pencil beam proton therapy and iscocentric cone beam CT during cancer treatment. 

An analysis conducted by Grand View Research has estimated that the global healthcare 3D printing market will have a compound annual growth rate of 15.6 percent from 2014 to 2020 and is estimated to be worth $1.13 billion by 2020.

Researchers at the Laser Zentrum Hannover eV (LZH) in Germany and the Technion-Israel Institute of Technology in Haifa, Israel, have developed an imaging technique that could enable the use of internal ultrasonic methods to gather information about heart tissues.

Whether or not the colorful images end up leading to novel therapies, the brain scans of people tripping on LSD captured in recent research at Imperial College London are worth a look. 

Clinical and neuroscience researchers in Japan and Providence, R.I., have put their heads together and come up with an algorithmic classifier that can distinguish between autistic and non-autistic brains as imaged with fMRI.